AI documentation built for rheumatology
Stop spending evenings documenting joint counts, disease activity scores, and biologic infusion notes. Eluve listens to your consultations and generates structured rheumatology notes — from SOAP documentation to infusion records — in real time.
75%
less time charting
2 min
average note turnaround
99%
documentation accuracy
Built for your workflow
Ambient Rheumatology Notes
Eluve listens to your encounter and generates structured notes — joint examinations, disease activity assessments, medication reviews, and treatment plans — without you typing a word.
Auto Billing & Coding
CPT codes for E/M visits, joint injections (20610/20611), and biologic infusions (96413) are suggested automatically. ICD-10 codes like M05, M06, and M32 are mapped to the specificity level payers require.
Disease Activity Score Capture
DAS28, CDAI, RAPID3, and other validated disease activity measures discussed during the visit are captured and trended automatically — giving you a longitudinal view of treatment response without manual data entry.
Biologic & DMARD Management
Medication histories for methotrexate, biologics, and JAK inhibitors are maintained across visits. Lab monitoring schedules, prior authorization status, and treatment escalation rationale are documented from the conversation.
Referral Letter Generation
Referral letters to orthopedics, physical therapy, dermatology, and other specialists are drafted automatically from the encounter — including disease history, current medications, and the clinical question.
Infusion Visit Documentation
Biologic infusion visits are documented with pre-infusion assessment, drug and dose, infusion duration, adverse reaction monitoring, and post-infusion status — structured for both clinical and billing requirements.
Every visit type, one AI scribe
Rheumatology encompasses complex diagnostic evaluations, ongoing disease management, infusion therapy, and procedural visits. Eluve handles all of them with specialty-tuned documentation.
New Patient Evaluation
Comprehensive autoimmune workup, multi-system review, serologic assessment, and differential diagnosis
RA Follow-Up
Disease activity scoring, DMARD and biologic efficacy review, lab monitoring, and treatment adjustment
Lupus Management
Multi-organ assessment, SLEDAI scoring, hydroxychloroquine monitoring, and flare management
Biologic Infusion
Pre-infusion screening, drug administration documentation, vital monitoring, and adverse reaction tracking
Joint Injection
Corticosteroid or viscosupplementation injections with procedure notes, laterality, and guidance documentation
Gout / Crystal Arthropathy
Acute flare management, urate-lowering therapy titration, and prophylaxis documentation
Vasculitis / Myositis
Complex autoimmune evaluations with multi-system examinations, immunosuppressive regimens, and monitoring plans
Osteoporosis Screening
DEXA interpretation, FRAX scoring, bisphosphonate management, and fracture risk counseling
Telemedicine Follow-Up
Remote disease activity assessment, medication review, lab result discussion, and treatment plan updates
Pre-Op Clearance
Immunosuppressant hold recommendations, perioperative risk assessment, and surgical clearance documentation
How a rheumatology visit works with Eluve
Patient history and labs at your fingertips
Eluve compiles the patient's disease activity trend, current DMARD and biologic regimen, recent labs (CBC, CMP, ESR, CRP, anti-CCP), imaging results, and prior authorization status into a concise pre-visit summary. You walk into the room ready to focus on the patient, not the chart.
You examine, Eluve documents
Focus on your joint exam, disease activity assessment, and treatment discussion. Eluve captures the conversation in the background — documenting tender and swollen joint counts, functional status, medication changes, and clinical reasoning. Whether it's a 15-minute follow-up or a 45-minute new patient evaluation for suspected lupus, the note matches the encounter complexity.
Notes, orders, and letters — done
Review your finished visit note with disease activity scores populated, generate referral letters to orthopedics or physical therapy, and confirm suggested billing codes — including modifiers for same-day injections. Sign off in under a minute and move to your next patient.
Better notes mean fewer denied claims and less unpaid work
Rheumatology billing is among the most complex in medicine — biologic infusions, same-day procedures, and multi-condition visits. The documentation gap costs practices tens of thousands per provider each year.
More
complete documentation per visit
When the ambient scribe captures the full encounter — every condition addressed, every clinical decision, every procedure — your documentation supports the true complexity of each visit without extra work.
Fewer
denied claims
Documentation that captures the clinical reasoning, medical necessity, and payer-specific detail from the start means fewer gaps for payers to deny on — and less time spent on appeals.
3x
More complete problem lists per visit
When documentation captures every condition discussed — not just the primary autoimmune diagnosis — practices see significantly more accurate coding and risk adjustment.
3 hrs
Saved per clinician per day
Less time on visit notes, infusion documentation, prior auth letters, and coding means you leave the clinic on time — or see the patients that were backing up your schedule.
If you ever get audited, your notes are ready
Biologic infusion billing, same-day procedure modifiers, and high-complexity E&M visits are audit magnets. Eluve structures every note so it holds up under scrutiny.
Disease Activity Documentation
Validated disease activity scores — DAS28, CDAI, RAPID3, SLEDAI — are captured and trended across visits, providing objective evidence of treatment response and medical necessity for ongoing biologic therapy.
Treatment Escalation Rationale
Every medication change documents the clinical reasoning — failed therapies, inadequate response, intolerance, or adverse effects — creating an audit trail that supports step therapy compliance and biologic necessity.
Infusion Billing Compliance
Start/stop times, rate escalation, pre-medications, vital monitoring, and drug waste documentation are structured per CMS requirements — so infusion claims are audit-ready from the moment you sign the note.
Same-Day Procedure Separation
When you perform an E&M visit and a joint injection on the same day, Eluve documents each service as a distinct encounter with separate clinical reasoning — supporting proper modifier -25 usage.
HIPAA-Compliant by Default
All data is encrypted in transit and at rest. Eluve is SOC 2 Type II certified and operates under a BAA with every practice. Your patient data is never used to train AI models.
See what Eluve generates
Every clinic is different. Switch between note styles to see how Eluve adapts to your preferred level of detail.
New Patient Evaluation — Suspected SLE
Chief Complaint
Referred by PCP for evaluation of joint pain, malar rash, and positive ANA.
History of Present Illness
32-year-old female referred for evaluation of 4-month history of bilateral hand and knee pain with morning stiffness lasting over 1 hour. Associated with intermittent malar rash worsened by sun exposure, fatigue, and oral ulcers. Reports hair thinning over the past 2 months. Denies Raynaud phenomenon, pleuritic chest pain, or lower extremity edema. No history of miscarriage or DVT. PCP obtained ANA — positive at 1:640, homogeneous pattern. No prior rheumatologic evaluation.
Past Medical History
Migraine headaches. No prior autoimmune diagnoses. Medications: Sumatriptan PRN, oral contraceptive pill. Allergies: NKDA. Family history: Mother with Hashimoto thyroiditis. Maternal aunt with SLE.
Review of Systems
Constitutional: Fatigue, no fevers or weight loss. Skin: Malar rash with photosensitivity. Hair thinning. No discoid lesions. Musculoskeletal: Bilateral MCP, PIP, and knee pain with morning stiffness >1 hour. Oral: Recurrent painless oral ulcers. Pulmonary: No pleurisy or dyspnea. Renal: No foamy urine or hematuria. Hematologic: Easy bruising, no recurrent infections. Neurologic: Migraines as above, no seizures or cognitive changes.
Examination
Vitals: BP 118/72, HR 76, Temp 98.6F. General: Alert, well-appearing, no acute distress. Skin: Erythematous malar rash sparing nasolabial folds. No discoid lesions. Diffuse hair thinning without scarring alopecia. Oral: Two small painless ulcers on hard palate. Musculoskeletal: Tenderness at bilateral MCP2-4 and PIP2-3 without synovitis. Bilateral knee tenderness without effusion. Full ROM all joints. Cardiopulmonary: Heart regular, no rub. Lungs clear bilaterally. Abdomen: Soft, non-tender, no organomegaly. Extremities: No edema. No digital cyanosis.
Assessment
32-year-old female with arthralgia, malar rash, photosensitivity, oral ulcers, hair thinning, and ANA 1:640 homogeneous. Meets 4 SLICC criteria (malar rash, oral ulcers, arthritis, ANA positivity). High clinical suspicion for systemic lupus erythematosus. DDx: Mixed connective tissue disease, undifferentiated connective tissue disease.
Plan
1. Labs: dsDNA antibodies, anti-Smith, anti-RNP, complement C3/C4, CBC with differential, CMP, urinalysis with microscopy, urine protein-to-creatinine ratio, antiphospholipid panel (anticardiolipin, beta-2 glycoprotein, lupus anticoagulant), ESR, CRP 2. Start hydroxychloroquine 200mg BID — counsel on baseline ophthalmologic screening within first year 3. Sunscreen SPF 50+ daily, strict photoprotection counseling 4. Discuss diagnosis, disease course, and importance of adherence 5. Ophthalmology referral for baseline retinal exam prior to hydroxychloroquine 6. Follow-up in 4-6 weeks to review serologies and treatment response 7. Patient to call if new symptoms: pleuritic chest pain, leg swelling, worsening rash, or decreased urine output
Generated from a 45-minute new patient evaluation
Frequently asked questions
Yes. Eluve is purpose-built for rheumatology workflows, trained on the terminology, note formats, and clinical patterns unique to autoimmune and inflammatory disease management. It understands joint examination documentation, disease activity scoring, biologic step-therapy rationale, and infusion visit structures — so your notes reflect how rheumatologists actually practice.
Eluve captures the components of disease activity assessments discussed during the encounter — tender and swollen joint counts, inflammatory markers, and patient global assessment — and populates validated scores like DAS28-ESR, CDAI, and RAPID3. Autoimmune panel results including ANA, anti-CCP, RF, dsDNA, and complement levels are documented with your clinical interpretation and trended across visits.
Yes. Eluve captures your treatment escalation rationale across encounters, including specific failed therapies with agent names, doses, durations, and reasons for discontinuation. It compiles disease activity scores, functional impact, and lab values into a structured narrative that prior authorization reviewers require — reducing the back-and-forth that delays biologic approvals.
Yes. Eluve is trained on rheumatology encounters and recognizes specialty-specific workflows including joint examinations, disease activity scoring (DAS28, CDAI, RAPID3), DMARD and biologic management, infusion visits, and autoimmune diagnostic workups.
Yes. When you discuss disease activity measures during the visit — tender and swollen joint counts, inflammatory markers, patient global assessment — Eluve captures the data and populates validated scores like DAS28-ESR, CDAI, and RAPID3 in your note.
Yes. Eluve suggests E/M codes based on medical decision-making complexity, plus procedure codes for joint injections (CPT 20610/20611), arthrocentesis, and biologic infusions (CPT 96413/96415). ICD-10 codes are mapped to the specificity level payers require — distinguishing seropositive from seronegative RA, laterality, and organ involvement.
Eluve generates structured infusion visit notes including pre-infusion screening, drug and dose, infusion rate and duration, vital sign monitoring, adverse reaction documentation, and post-infusion status. Each note is structured for both clinical accuracy and billing compliance.
Yes. Eluve captures the clinical reasoning for treatment escalation — including failed therapies, disease activity scores, and functional impact — and structures it in the format prior authorization reviewers look for. This reduces back-and-forth with insurers when starting biologics or JAK inhibitors.
Eluve is HIPAA compliant and SOC 2 Type II certified. All data is encrypted in transit and at rest. We offer a Business Associate Agreement (BAA) for every practice. Your data is never used to train AI models.
Most rheumatology practices are up and running within a day. Eluve integrates with your existing EHR and adapts to your documentation preferences — whether you use SOAP format, problem-oriented notes, or custom templates for different visit types.
Yes. Eluve is designed for rheumatology practices managing both office visits and in-house infusion suites. Notes are generated in real time for each encounter type, so your documentation keeps pace even when you're seeing follow-ups between infusion checks.
Ready to reclaim your evenings?
Join hundreds of rheumatologists who've eliminated documentation backlogs, after-hours charting, and manual infusion notes with Eluve.
Request a Demo